المشهد
Smart Reader
Ready to play
Smart Reader
Ready to play
Source: المشهد
9 Daysالمشهد
Ready to play
Ready to play
Source: المشهد
9 DaysA recent study revealed that continuous glucose monitoring devices, which are commonly used by insulin-dependent diabetes patients, may also benefit those with type 2 diabetes who do not require insulin. During a six-month trial, participants using the Dexcom G7 device experienced a nearly 1% reduction in hemoglobin A1c levels compared to standard care, along with improved glucose balance and maintaining blood sugar within the target range for approximately five additional hours per day. Researchers confirmed that most participants continued using the device daily even after the study concluded. These findings are particularly significant because they suggest that glucose monitoring devices could be more broadly effective in improving the management of type 2 diabetes.
Notice: This Is an AI-Generated Summary
Comments (0)